{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:48:04Z","timestamp":1788295684932,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701800"],"award-info":[{"award-number":["2021YFC2701800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Metagenomic next-generation sequencing (mNGS) plays a critical role in the rapid detection of infectious pathogens. We aimed to analyze the clinical characteristics of\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      infection in children without HIV infection and to evaluate the performance of mNGS in distinguishing\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      colonization from true infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A multicenter, retrospective analysis was conducted on critically ill, non-HIV-infected pediatric patients who tested positive for\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      via mNGS analysis of bronchoalveolar lavage fluid (BALF). Group differences were assessed using Mann\u2013Whitney U-tests (for continuous data) and chi-square tests (for categorical data). Discriminatory performance was evaluated by calculating the area under the receiver operating characteristic curve.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 59 HIV-negative children (age range: 2 months to 14 years) from four children\u2019s hospitals were included and classified into two groups based on\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      status:\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      pneumonia (PCP;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200951) and\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      colonization (PCC;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098). Compared with the PCC group, the PCP group had significantly higher serum C-reactive protein levels and median\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      read counts in mNGS (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The optimal threshold value for discriminating\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      infection from colonization appeared to be 556 reads (sensitivity, 77.6%; specificity, 100.0%). Eighteen patients (35.3%) in the PCP group died. Compared with survivors, these patients were significantly younger, had lower T-cell subset counts (CD3\n                      <jats:sup>+<\/jats:sup>\n                      , CD4\n                      <jats:sup>+<\/jats:sup>\n                      , and CD8\n                      <jats:sup>+<\/jats:sup>\n                      ), and a higher prevalence of primary immunodeficiency (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      BALF mNGS analysis may have utility for differentiating between colonization and infection by\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      , warranting further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04163-9","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:47:53Z","timestamp":1770428873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metagenomic next-generation sequencing to detect Pneumocystis jirovecii pneumonia in critically ill, HIV-negative children: a retrospective multicenter study"],"prefix":"10.1186","volume":"26","author":[{"given":"Liming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangfeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"1","key":"4163_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.idc.2009.10.010","volume":"24","author":"E Catherinot","year":"2010","unstructured":"Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am. 2010;24(1):107\u201338.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"4163_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","volume":"96","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF, Sch\u00e4fer G, Hoenigl M, G\u00fcnther G, Hoffmann C, Kalsdorf B, et al. Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration. 2018;96(1):52\u201365.","journal-title":"Respiration"},{"issue":"10","key":"4163_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/14787210.2019.1671823","volume":"17","author":"C Cill\u00f3niz","year":"2019","unstructured":"Cill\u00f3niz C, Domined\u00f2 C, \u00c1lvarez-Mart\u00ednez MJ, Moreno A, Garc\u00eda F, Torres A, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther. 2019;17(10):787\u2013801.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"4163_CR4","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/jac\/dkw155","volume":"71","author":"C Cordonnier","year":"2016","unstructured":"Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2379\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"4163_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.medcli.2019.01.010","volume":"152","author":"BP Braga","year":"2019","unstructured":"Braga BP, Prieto-Gonz\u00e1lez S, Hern\u00e1ndez-Rodr\u00edguez J. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases. Med Clin (Barc). 2019;152(12):502\u20137.","journal-title":"Med Clin (Barc)"},{"issue":"Supplement2","key":"4163_CR6","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1093\/cid\/ciaa1805","volume":"72","author":"K Lagrou","year":"2021","unstructured":"Lagrou K, Chen S, Masur H, Viscoli C, Decker CF, Pagano L, et al. Pneumocystis jirovecii disease: basis for the revised EORTC\/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus. Clin Intect Dis. 2021;72(Supplement2):S114\u201320.","journal-title":"Clin Intect Dis"},{"issue":"3","key":"4163_CR7","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s40121-021-00482-y","volume":"10","author":"J Jiang","year":"2021","unstructured":"Jiang J, Bai L, Yang W, Peng W, An J, Wu Y, et al. Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii pneumonia in non-HIV-infected patients: A retrospective study. Infect Dis Ther. 2021;10(3):1733\u201345.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"4163_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jinf.2018.11.005","volume":"79","author":"T Pan","year":"2019","unstructured":"Pan T, Tan R, Qu H, Weng X, Liu Z, Li M, et al. Next-generation sequencing of the BALF in the diagnosis of community-acquired pneumonia in immunocompromised patients. J Infect. 2019;79(1):61\u201374.","journal-title":"J Infect"},{"issue":"9","key":"4163_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s10096-021-04254-x","volume":"40","author":"F Zhang","year":"2021","unstructured":"Zhang F, Chen J, Huang H, Deng X, Zhang W, Zeng M, et al. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. Eur J Clin Microbiol. 2021;40(9):1933\u201342.","journal-title":"Eur J Clin Microbiol"},{"key":"4163_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2147\/IDR.S358483","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhu H, Zheng Y. Detection of Pneumocystis jirovecii pneumonia in infants with non-human immunodeficiency virus admitted to pediatric intensive care using metagenomics next-generation sequencing. Infect Drug Resist. 2022;15:1889\u2013902.","journal-title":"Infect Drug Resist"},{"key":"4163_CR11","doi-asserted-by":"crossref","unstructured":"Chen H, Liang Y, Wang R, Wu Y, Zhang X, Huang H, et al. Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii pneumonia in critically pediatric patients. Ann Clin Microb Anti. 2023;22(1):6.","DOI":"10.1186\/s12941-023-00555-5"},{"issue":"1","key":"4163_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12890-024-03135-1","volume":"24","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu T, Ming M, Shen M, Zhang Y, Chen H, et al. Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study. BMC Pulm Med. 2024;24(1):338.","journal-title":"BMC Pulm Med"},{"key":"4163_CR13","doi-asserted-by":"crossref","unstructured":"Liu L, Yuan M, Shi Y, Su X. Clinical performance of BAL metagenomic next-generation sequence and serum (1,3)-\u03b2-D-Glucan for differential diagnosis of Pneumocystis jirovecii pneumonia and Pneumocystis jirovecii colonisation. Front Cell Infect Mi. 2021;11:784236.","DOI":"10.3389\/fcimb.2021.784236"},{"issue":"8","key":"4163_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696\u2013726.","journal-title":"J Clin Immunol"},{"issue":"1","key":"4163_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1183\/09031936.00.15121700","volume":"15","author":"J de Blic","year":"2000","unstructured":"de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, et al. Bronchoalveolar lavage in children. ERS task force on Bronchoalveolar lavage in children. Eur Respiratory Soc Eur Respir J. 2000;15(1):217\u201331.","journal-title":"Eur Respiratory Soc Eur Respir J"},{"issue":"01","key":"4163_CR16","first-page":"1","volume":"26","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang W, Yi B, Feng Z, Yang K. Clinical practice guidelines for Bronchoalveolar lavage in Chinese children (2024). Chin J Contemp Pediatr. 2024;26(01):1\u201313.","journal-title":"Chin J Contemp Pediatr"},{"key":"4163_CR17","doi-asserted-by":"crossref","unstructured":"Yan G, Liu J, Chen W, Chen Y, Cheng Y, Tao J, et al. Metagenomic next-generation sequencing of bloodstream microbial cell-free nucleic acid in children with suspected sepsis in pediatric intensive care unit. Front Cell Infect Mi. 2021;11:665226.","DOI":"10.3389\/fcimb.2021.665226"},{"key":"4163_CR18","doi-asserted-by":"crossref","unstructured":"Zhang C, Liu T, Wang Y, Chen W, Liu J, Tao J, et al. Metagenomic next-generation sequencing of Bronchoalveolar lavage fluid from children with severe pneumonia in pediatric intensive care unit. Front Cell Infect Mi. 2023;13:1082925.","DOI":"10.3389\/fcimb.2023.1082925"},{"issue":"3","key":"4163_CR19","first-page":"159","volume":"23","author":"M Zakrzewska","year":"2021","unstructured":"Zakrzewska M, Roszkowska R, Zakrzewski M, Maciorkowska E. Pneumocystis pneumonia: still a serious disease in children. J Mother Child. 2021;23(3):159\u201362.","journal-title":"J Mother Child"},{"issue":"5","key":"4163_CR20","doi-asserted-by":"publisher","first-page":"e148822","DOI":"10.1128\/spectrum.01488-22","volume":"10","author":"A Yang","year":"2022","unstructured":"Yang A, Chen C, Hu Y, Zheng G, Chen P, Xie Z, et al. Application of metagenomic next-generation sequencing (mNGS) using Bronchoalveolar lavage fluid (BALF) in diagnosing pneumonia of children. Microbiol Spectr. 2022;10(5):e148822.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4163_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12879-022-07381-8","volume":"22","author":"P Lin","year":"2022","unstructured":"Lin P, Chen Y, Su S, Nan W, Zhou L, Zhou Y, et al. Diagnostic value of metagenomic next-generation sequencing of Bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infect Dis. 2022;22(1):416.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4163_CR22","doi-asserted-by":"publisher","first-page":"102823","DOI":"10.1016\/j.jiph.2025.102823","volume":"18","author":"H Shen","year":"2025","unstructured":"Shen H, Zhang X, Xu J, Ma W, Chen W, Wang Y, et al. Real-world pathogen diagnosis in critically ill infected children: A retrospective study using metagenomic next-generation sequencing with different enrichment strategies. J Infect Public Health. 2025;18(8):102823.","journal-title":"J Infect Public Health"},{"issue":"12","key":"4163_CR23","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.7150\/thno.45554","volume":"10","author":"D Han","year":"2020","unstructured":"Han D, Li R, Shi J, Tan P, Zhang R, Li J. Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing. Theranostics. 2020;10(12):5501\u201313.","journal-title":"Theranostics"},{"issue":"RR\u20134","key":"4163_CR24","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National institutes of Health, and the HIV medicine association of the infectious diseases society of America. MMWR Recomm Rep. 2009;58(RR\u20134):1\u2013207.","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"4163_CR25","first-page":"D5590","volume":"2014","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Db Syst Rev. 2014;2014(10):D5590.","journal-title":"Cochrane Db Syst Rev"},{"issue":"1","key":"4163_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/crj.12467","volume":"12","author":"C Ling","year":"2018","unstructured":"Ling C, Qian S, Wang Q, Zeng J, Jia X, Liu J, et al. Pneumocystis pneumonia in non-HIV children: a 10-year retrospective study. Clin Respir J. 2018;12(1):16\u201322.","journal-title":"Clin Respir J"},{"issue":"9","key":"4163_CR27","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.jiph.2025.102831","volume":"18","author":"J Wang","year":"2025","unstructured":"Wang J, Wang J, Yuan D, Sun C, Hou L, Zhang Y, et al. Metagenomic next-generation sequencing-based diagnosis of Pneumocystis jirovecii pneumonia in patients without human immunodeficiency virus infection: A dual-center retrospective propensity matched study. J Infect Public Health. 2025;18(9):102831.","journal-title":"J Infect Public Health"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04163-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:59:28Z","timestamp":1773226768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04163-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4163"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04163-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7061414\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee approved this study at the Children\u2019s Hospital of Fudan University with an IRB of 2019\u2009\u2212\u2009312.This study was conducted in accordance with the Declaration of Helsinki.Informed consent to participate was taken from parents\/legal guardians of minor participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}